Navigation Links
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
Date:6/7/2009

reated group. The most common gastrointestinal-related adverse events were nausea, diarrhea and vomiting, and most were transient. Other adverse events reported included flu-like symptoms.

About LEAD(TM) (Liraglutide Effect and Action in Diabetes)

The LEAD(TM) program comprises five randomized, controlled, double-blinded studies plus one open-label head-to-head study against exenatide and involved more than 4,000 patients with type 2 diabetes in 40 countries.

About Liraglutide

Once-daily liraglutide is the first human glucagon-like peptide-1 (GLP-1) analog developed for the treatment of type 2 diabetes. Liraglutide works by stimulating the release of insulin only when blood sugar levels are high. Weight loss with liraglutide is attributed to the fact that it slows gastric emptying and leads to increased satiety after meals. Liraglutide is naturally broken down in the body and does not require renal excretion.

On May 23, 2008, Novo Nordisk submitted a New Drug Application to the Food and Drug Administration (FDA) in the U.S., as well as a marketing authorization application to the European Medicines Agency (EMEA), for the approval of liraglutide for the treatment of people with type 2 diabetes. A New Drug Application was also submitted for approval in Japan on July 14, 2008.

On April 23, 2009, Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) under the EMEA adopted a positive opinion, recommending marketing authorization of liraglutide for treatment of type 2 diabetes in Europe.

In the U.S., a regulatory decision is pending.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pha
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
2. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
10. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
11. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Flexpoint Ford, a private ... sectors, today announced that it has entered into a ... Stuart to form Kastle Therapeutics, LLC (Kastle).  The ... will focus on acquiring, developing and commercializing pharmaceuticals targeted ... opportunities include select therapies already approved for marketing, as ...
(Date:7/30/2015)... FRAMINGHAM, Mass., July 30, 2015   HeartWare ... leading innovator of less invasive, miniaturized circulatory support ... heart failure, today announced total revenue of $73.6 ... compared to $70.1 million for the quarter ended ... by approximately $6.0 million, or nine percentage points, ...
(Date:7/30/2015)... 30, 2015  IDEXX Laboratories, Inc. (NASDAQ: IDXX ... 2015 of $413 million, an increase of 6% compared ... of the US dollar reduced reported revenue growth by ... quarter was 11%, supported by strong growth in the ... share ("EPS") was $0.60 for the quarter, an increase ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile ... lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. Dr. ... made him popular with many patients from around the world. , “Like treatment of ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of its ... to apply lotion or medication to a hard-to-reach area. This invention is patented. , ... to the back, and provides thorough coverage. The product would prevent the user from ...
(Date:7/30/2015)... , ... July 30, 2015 , ... After conducting a ... St. John’s Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) ... With more than 25 years of healthcare leadership experience, Walsh is an expert in ...
(Date:7/30/2015)... ... July 30, 2015 , ... According ... do not find a complete removable denture acceptable. The demand for dental implants ... that incorporate less expensive, immediate loading techniques will have the ability to offer ...
(Date:7/30/2015)... ... July 30, 2015 , ... Diagnotes, ... and reporting for reimbursement from the Centers for Medicare & Medicaid Services (CMS) ... providers are experimenting with manual data capture or, in many cases, just deciding ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3
... ... Removal System , ... (Vocus) January 8, 2010 -- After more than 20 years with very little innovation, the ... a new tool for cast removal. , , , , ,With an operating sound level ...
... ... Make Moves to Advance Expansion as EHS Industry Explodes. , ... Vancouver, Washington (PRWEB) January 8, 2010 -- ... as Vice President of Partners and Strategy. In this role, Jim will focus ...
... , , , , WEST ... , a leading provider of digital office equipment, today ... professionals seeking to streamline paper-intensive medical processes. Held in seven ... both the healthcare and information technology industries on critical steps ...
... Calif., Jan. 8 TRIA Beauty, the leader in ... (OTC) clearance from the United States Food and Drug ... for at-home use. The patented blue light technology ... inflammatory acne. , "This new platform validates TRIA Beauty,s ...
... , FRANKLIN LAKES, N.J., Jan. 8 ... BDX ), a leading global medical technology ... President,s Emergency Plan for AIDS Relief (PEPFAR) will increase ... health systems in developing countries. , BD currently collaborates ...
... with asthma, heart and lung disease, among others, agency ... U.S. Environmental Protection Agency on Thursday proposed stricter standards ... of health problems, including aggravated asthma and premature death ... standards, if adopted by the agency after a 60-day ...
Cached Medicine News:Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2Health News:Seasoned Executive Joins Safetec To Accelerate Growth 2Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 2Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 3Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 4Health News:TRIA Beauty Announces FDA Clearance 2Health News:BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems 2Health News:BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems 3Health News:EPA Unveils Stricter Smog Standards 2Health News:EPA Unveils Stricter Smog Standards 3
... The full color LCD ... familiar joystick controls, enable any ... make quick and accurate measurements.,Measurement ... the color screen, and results ...
... Patients who need punctal ... dry eye relief. They also ... be as comfortable and as ... why Alcon punctal plugs are ...
... to diagnostic images and reports, the powerful ... scaled to meet the needs of virtually ... Web PACS system allows clinicians, referring physicians, ... view images and information on-site or at ...
... SonoAce 9900 is a ... ultrasound system, with an ... DICOM compatible, designed for ... imaging, obstetrics, gynecology, perinatology, ...
Medicine Products: